Research & Data

Our unique data streams allow scientists to measure abuse rates of non-ADFs and potentially ADFs relative to comparative products, evaluate the route of administration profile, and analyze the reactions of abusers to ADFs, including efforts to develop and disseminate recipes designed to defeat the ADF properties of the new formulation.

IBH’s Data Analysis Services, NAVIPPRO, work to better understand prescription opioid and stimulant use/abuse and the effectiveness of abuse-deterrent formulations. NAVIPPRO offers surveillance, risk management, and epidemiological studies required for FDA-regulated products that have abuse liability and pose potential health risks.